Deucravacitinib in the Treatment of Cicatricial Alopecias | MicrobiomeTrials← Back to trialsNCT07508488
Deucravacitinib in the Treatment of Cicatricial Alopecias
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-28Est. Completion: 2028-06-30
Enrollment target: 20 participants Locations- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Other microbiome trials you might be interested in
Cicatricial Alopecia
Alopecia could be subdivided into two main groups of diseases: non-scarring alopecia, such as male pattern baldness, or …
New York, United StatesCompleted Mar 20, 2025
Central Centrifugal Cicatricial AlopeciaLichen Planopilaris
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adu…
New York, United StatesEst. completion Apr 5, 2027